Welcome to our virtual exhibit booth!


About Us

Signatera is a personalized ctDNA test for molecular residual disease (MRD) detection and recurrence monitoring in patients previously diagnosed with cancer. Signatera’s tumor-informed assay is optimized to detect low levels of ctDNA, with high accuracy in identifying MRD and recurrence with longer lead times. Signatera has been clinically validated in multiple cancer types including colorectal, non-small cell lung, breast, and bladder cancers.

Look deeper at natera.com/oncology

Signatera CRC Brochure

Signatera Example Test Report

Signatera Patient Brochure

Signatera Requisition Form

Signatera Standing Order Sheet

Social Media Links